Abstract:The current outbreak of the pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) demands its rapid, convenient, and large-scale diagnosis to downregulate its spread within as well as across the communities. But the reliability, reproducibility, and selectivity of majority of such diagnostic tests fail when they are tested either to a viral load at its early representation or to a viral gene mutated during its current spread. In this regard, a selective "naked-eye" detection of SARS-CoV-2 is highly desirable, which can be tested without accessing any advanced instrumental techniques. We herein report the development of a colorimetric assay based on gold nanoparticles (AuNPs), when capped with suitably designed thiol-modified antisense oligonucleotides (ASOs) specific for N-gene (nucleocapsid phosphoprotein) of SARS-CoV-2, could be used for diagnosing positive COVID-19 cases within 10 min from the isolated RNA samples. The thiol-modified ASO-capped AuNPs agglomerate selectively in the presence of its target RNA sequence of SARS-CoV-2 and demonstrate a change in its surface plasmon resonance. Further, the addition of RNaseH cleaves the RNA strand from the RNA–DNA hybrid leading to a visually detectable precipitate from the solution mediated by the additional agglomeration among the AuNPs. The selectivity of the assay has been monitored in the presence of MERS-CoV viral RNA with a limit of detection of 0.18 ng/μL of RNA having SARS-CoV-2 viral load. Thus, the current study reports a selective and visual "naked-eye" detection of COVID-19 causative virus, SARS-CoV-2, without the requirement of any sophisticated instrumental techniques.The following files are available online free of charge: N-gene sequence, figure S1–S10, movie S1–S3, table S1–S4 and supporting references. The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c03822?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c03822</a>.(<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">PDF</a>)Screenshots of Au-ASOmix nanoparticles as observed through zetaview (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_002.mp4">MP4</a>)Screenshots of Au-ASOmix nanoparticles as observed through zetaview after the addition of total RNA (1 ng/μL) isolated from the Vero cells infected with SARS-CoV-2 (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_003.mp4">MP4</a>)The movement of agglomerated Au-ASOmix nanoparticles as a string in presence of SARS-CoV-2 RNA (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_004.mp4">MP4</a>)This article has not yet been cited by other publications.

Thermoplasmonic-Assisted Cyclic Cleavage Amplification for Self-Validating Plasmonic Detection of SARS-CoV-2

Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection

An Electrochemiluminescence Sensing Platform Combining Entropy-Driven Amplification Strategy and Inverted DNA Tetrahedral Nanomachines for Detecting SARS-CoV-2 Specific Gene

Proof of Concept for a Quick and Highly Sensitive On-Site Detection of SARS-CoV-2 by Plasmonic Optical Fibers and Molecularly Imprinted Polymers

A CRISPR/Cas13a-powered catalytic hairpin assembly evanescent wave fluorescence biosensor for target amplification-free SARS-CoV-2 detection

Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection

An ultra-sensitive and specific nanoplasmonic-enhanced isothermal amplification platform for the ultrafast point-of-care testing of SARS-CoV-2

Plasmon‐enhanced FRET biosensor based on Tm3+/Er3+ co‐doped core‐shell upconversion nanoparticles for ultrasensitive virus detection

A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2

Efficient Microfluidic-Based Air Sampling/Monitoring Platform for Detection of Aerosol SARS-CoV-2 On-site

Bioinspired Plasmo-virus for Point-of-Care SARS-CoV-2 Detection

Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology

One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device

CRISPR-Cas12a Coupled with Universal Gold Nanoparticle Strand-Displacement Probe for Rapid and Sensitive Visual SARS-CoV-2 Detection

Nanomechanical assay for ultrasensitive and rapid detection of SARS-CoV-2 based on peptide nucleic acid

Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device

Rapid One-Step Detection of Viral Particles Using an Aptamer-Based Thermophoretic Assay

Gradient nanoplasmonic imaging metasurface for rapid and label-free detection of SARS-CoV-2 sequences

Plasmonic LAMP: Improving the Detection Specificity and Sensitivity for SARS‐CoV‐2 by Plasmonic Sensing of Isothermally Amplified Nucleic Acids (Small 12/2022)

Single- and Two-Stage, Closed-Tube, Point-of-Care, Molecular Detection of SARS-CoV-2

Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles